1. |
Masrori P, Vaesen Bentein H, Raskin J, et al. Caspr2 autoantibody-associated Morvan syndrome predating thymoma relapse by 30 months. Lung Cancer, 2021, 153: 117-119.
|
2. |
Abou-Zeid E, Boursoulian LJ, Metzer WS, et al. Morvan syndrome: a case report and review of the literature. J Clin Neuromuscul Dis, 2012, 13(4): 214-227.
|
3. |
Vale TC, Pedroso JL, Dutra LA, et al. Morvan syndrome as a paraneoplastic disorder of thymoma with anti-CASPR2 antibodies. Lancet, 2017, 389(10076): 1367-1368.
|
4. |
Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain, 2010, 133(9): 2734-2748.
|
5. |
Irani SR, Pettingill P, Kleopa KA, et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol, 2012, 72(2): 241-255.
|
6. |
Walusinski O, Honnorat J. Augustin Morvan (1819-1897), a little-known rural physician and neurologist. Rev Neurol (Paris), 2013, 169(1): 2-8.
|
7. |
Lee EK, Maselli RA, Ellis WG, et al. Morvan’s fibrillary chorea: a paraneoplastic manifestation of thymoma. J Neurol Neurosurg Psychiatry, 1998, 65(6): 857-862.
|
8. |
Winger DI, Spiegler P, Trow TK, et al. Radiology-Pathology Conference: pulmonary hyalinizing granuloma associated with lupus-like anticoagulant and Morvan’s syndrome. Clin Imaging, 2007, 31(4): 264-268.
|
9. |
Madrid A, Gil-Peralta A, Gil-Néciga E, et al. Morvan’s fibrillary chorea: remission after plasmapheresis. J Neurol, 1996, 243(4): 350-353.
|
10. |
Ma D, Xiang Q, Mo Z, et al. A case series: Three cases of Morvan’s syndrome as a rare autoimmune disorder with anti-Caspr2 antibody. Medicine (Baltimore), 2024, 103(42): e40159.
|
11. |
Masood W, Lui F, Sitammagari KK. Morvan syndrome//StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.
|
12. |
曾艳平, 解燕春, 罗瑛, 等. 莫旺综合征 2 例报道及文献复习. 神经损伤与功能重建, 2025, 20(3): 183-186.
|
13. |
Barber PA, Anderson NE, Vincent A. Morvan’s syndrome associated with voltage-gated K+ channel antibodies. Neurology, 2000, 54(3): 771-772.
|
14. |
Graus F, Cordon-Cardo C, Posner JB. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology, 1985, 35(4): 538-543.
|
15. |
Villagrán-García M, Farina A, Muñiz-Castrillo S, et al. Revisiting anti-Hu paraneoplastic autoimmunity: phenotypic characterization and cancer diagnosis. Brain Commun, 2023, 5(5): fcad247.
|
16. |
Maskery M, Chhetri SK, Dayanandan R, et al. Morvan syndrome: a case report with patient narrative and video. Neurohospitalist, 2016, 6(1): 32-35.
|
17. |
Kannoth S. Paraneoplastic neurologic syndrome: a practical approach. Ann Indian Acad Neurol, 2012, 15(1): 6-12.
|